Page last updated: 2024-09-05

sb 203580 and ic 261

sb 203580 has been researched along with ic 261 in 3 studies

Compound Research Comparison

Studies (sb 203580)	Trials (sb 203580)	Recent Studies (post-2010) (sb 203580)	Studies (ic 261)	Trials (ic 261)	Recent Studies (post-2010) (ic 261)
3,489	4	1,137	10	0	3
3,489	4	1,137	43	0	24

Protein Interaction Comparison

Protein	Taxonomy	ic 261 (IC50)
Casein kinase I isoform alpha	Homo sapiens (human)	1.12
Casein kinase I isoform delta	Homo sapiens (human)	1.785
Casein kinase I isoform epsilon	Homo sapiens (human)	1

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alessi, DR; Arthur, JS; Bain, J; Cohen, P; Elliott, M; Hastie, CJ; Klevernic, I; McLauchlan, H; Plater, L; Shpiro, N	1
Abadleh, M; Bischof, J; Hauser, D; Hirner, H; Knippschild, U; Laufer, S; Peifer, C; Schattel, V	1
Munoz, L	1

Reviews

1 review(s) available for sb 203580 and ic 261

Article	Year
Non-kinase targets of protein kinase inhibitors. Nature reviews. Drug discovery, 2017, Volume: 16, Issue:6 Topics: Animals; Drug Design; Drug Evaluation, Preclinical; Humans; Molecular Targeted Therapy; Protein Kinase Inhibitors; Protein Kinases	2017

Other Studies

2 other study(ies) available for sb 203580 and ic 261

Article	Year
The selectivity of protein kinase inhibitors: a further update. The Biochemical journal, 2007, Dec-15, Volume: 408, Issue:3 Topics: Amino Acid Sequence; Animals; Cell Line; Drug Design; Enzyme Activation; Humans; Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Recombinant Proteins; Spodoptera	2007
3,4-Diaryl-isoxazoles and -imidazoles as potent dual inhibitors of p38alpha mitogen activated protein kinase and casein kinase 1delta. Journal of medicinal chemistry, 2009, Dec-10, Volume: 52, Issue:23 Topics: Adenosine Triphosphate; Amino Acid Sequence; Animals; Binding, Competitive; Casein Kinase Idelta; Cell Line; Drug Discovery; Enzyme Inhibitors; Humans; Imidazoles; Inhibitory Concentration 50; Isoxazoles; Mitogen-Activated Protein Kinase 14; Models, Molecular; Molecular Sequence Data; Mutation; Protein Conformation; Rats; Trophoblasts	2009

Article

Year

The selectivity of protein kinase inhibitors: a further update.

The Biochemical journal, 2007, Dec-15, Volume: 408, Issue:3

Topics: Amino Acid Sequence; Animals; Cell Line; Drug Design; Enzyme Activation; Humans; Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Recombinant Proteins; Spodoptera

2007

3,4-Diaryl-isoxazoles and -imidazoles as potent dual inhibitors of p38alpha mitogen activated protein kinase and casein kinase 1delta.

Journal of medicinal chemistry, 2009, Dec-10, Volume: 52, Issue:23

Topics: Adenosine Triphosphate; Amino Acid Sequence; Animals; Binding, Competitive; Casein Kinase Idelta; Cell Line; Drug Discovery; Enzyme Inhibitors; Humans; Imidazoles; Inhibitory Concentration 50; Isoxazoles; Mitogen-Activated Protein Kinase 14; Models, Molecular; Molecular Sequence Data; Mutation; Protein Conformation; Rats; Trophoblasts

2009